Agüero Claudio A, Sarraquigne María P, Parisi Claudio A S, Mariño Andrea I, López Karina, Menéndez Porfirio Betina, Sasia Laura, Lozano Alejandro, Bovina Martijena María Del Pilar, Gervasoni María E, Bózzola Martín, Colella Mauricio, Saranz Ricardo, Orellana Julio, Máspero Jorge F, Seisdedos Viviana, Behrends Ilse, Blanco Adolfo, Dayán Patricia, Matta Ruffolo Mónica, Aráoz Irene, Casaniti Cristina, García Jorge, Skrie Víctor, García Marcela, Suárez García Juan M, Orellano Fabio, Luconi Natalia, Bandin Gloria
Comité Nacional de Alergia, Sociedad Argentina de Pediatría, Ciudad Autónoma de Buenos Aires, Argentina.
Arch Argent Pediatr. 2023 Apr 1;121(2):e202202894. doi: 10.5546/aap.2022-02894.
Allergic rhinitis (AR) is one of the most common chronic diseases in children. However, it remains underdiagnosed and undertreated. Its prevalence has increased in recent years and varies from 2 to 25 %. Symptoms include sneezing, itching, runny nose, and nasal congestion. A correct diagnosis and treatment of AR and its comorbidities such as rhinosinusitis with or without nasal polyposis, conjunctivitis, otitis media, bronchial asthma and respiratory tract infections, are important to reduce the negative impact on the quality of life of the patient and their relatives, and in medical costs. Specific allergen immunotherapy, in correctly selected patients, prevents new sensitizations and reduces bronchial hyperreactivity associated with AR. Taking into account all these reasons, the National Allergy Committee of the Sociedad Argentina de Pediatría proposes current evidence based recommendations.
变应性鼻炎(AR)是儿童最常见的慢性病之一。然而,其诊断不足和治疗不足的情况仍然存在。近年来其患病率有所上升,在2%至25%之间波动。症状包括打喷嚏、瘙痒、流鼻涕和鼻塞。正确诊断和治疗AR及其合并症,如伴或不伴鼻息肉的鼻窦炎、结膜炎、中耳炎、支气管哮喘和呼吸道感染,对于减少对患者及其亲属生活质量的负面影响以及医疗费用至关重要。对于正确选择的患者,特异性变应原免疫疗法可预防新的致敏反应,并降低与AR相关的支气管高反应性。考虑到所有这些原因,阿根廷儿科学会国家过敏委员会提出了当前基于证据的建议。